Armistice Capital’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.5M Sell
3,500,000
-500,000
-13% -$1.97M 0.45% 75
2025
Q4
$15.7M Sell
4,000,000
-200,000
-5% -$885K 0.38% 81
2025
Q3
$19.6M Sell
4,200,000
-600,000
-13% -$2.17M 0.62% 52
2025
Q2
$14.9M Sell
4,800,000
-636,000
-12% -$2.05M 0.57% 53
2025
Q1
$18.4M Buy
5,436,000
+40,000
+0.7% +$187K 0.49% 69
2024
Q4
$30.6M Buy
5,396,000
+196,000
+4% +$1.26M 0.71% 46
2024
Q3
$30.4M Hold
5,200,000
0.8% 37
2024
Q2
$41.1M Buy
5,200,000
+528,000
+11% +$4.43M 1.08% 33
2024
Q1
$43.5M Buy
4,672,000
+436,000
+10% +$3.68M 1.16% 29
2023
Q4
$35.8M Buy
4,236,000
+58,000
+1% +$421K 0.95% 36
2023
Q3
$32.4M Buy
4,178,000
+554,000
+15% +$5.06M 0.96% 39
2023
Q2
$41.5M Buy
3,624,000
+100,000
+3% +$1.03M 1.04% 39
2023
Q1
$27.2M Buy
3,524,000
+128,000
+4% +$1.02M 0.63% 51
2022
Q4
$20.7M Hold
3,396,000
0.56% 51
2022
Q3
$20.1M Buy
3,396,000
+832,000
+32% +$5.33M 0.51% 59
2022
Q2
$15.2K Buy
2,564,000
+564,000
+28% +$3.81M 0.26% 68
2022
Q1
$15.2M Buy
+2,000,000
New +$8.92M 0.43% 65
2021
Q4
Sell
-3,716,000
Closed -$9.77M 180
2021
Q3
$9.77M Hold
3,716,000
0.24% 91
2021
Q2
$15.3M Hold
3,716,000
0.4% 75
2021
Q1
$17.5M Buy
3,716,000
+324,000
+10% +$2.21M 0.56% 63
2020
Q4
$24.3M Buy
3,392,000
+692,000
+26% +$6.65M 1.09% 37
2020
Q3
$28.8M Buy
2,700,000
+622,000
+30% +$7.3M 1.34% 36
2020
Q2
$26.2M Sell
2,078,000
-158,000
-7% -$1.84M 1.38% 36
2020
Q1
$20.5M Buy
2,236,000
+612,000
+38% +$7.02M 1.5% 34
2019
Q4
$22.7M Buy
1,624,000
+528,000
+48% +$7.67M 1.82% 26
2019
Q3
$18.9M Buy
1,096,000
+160,000
+17% +$3.36M 1.75% 31
2019
Q2
$25.5M Sell
936,000
-600,000
-39% -$13.7M 2.36% 22
2019
Q1
$29.4M Sell
1,536,000
-1,300,000
-46% -$16.9M 2.42% 21
2018
Q4
$26.7M Buy
2,836,000
+1,112,000
+65% +$14.3M 2.92% 14
2018
Q3
$32.6M Buy
1,724,000
+1,292,000
+299% +$24.8M 2.66% 18
2018
Q2
$8.44M Buy
+432,000
New +$8.54M 0.73% 50

Other funds holding VYGR